Table 1.
Information About the Patients Used in the Stimulation Experiments
| Patient no. | Sex | Disease duration | Age | Comorbidity | Corticosteroid rates (mg/day) | PTPN22 1858 genotype |
|---|---|---|---|---|---|---|
| 1 | F | 19 | 46 | — | 25 | C-C |
| 2 | F | 31 | 55 | — | 30 | C-C |
| 3 | M | 15 | 41 | T1D, V, Gr | 37.5 | C-C |
| 4 | F | 0 | 26 | T1D | n/a | C-C |
| 5 | M | 15 | 55 | — | 31.25 | C-C |
| 6 | F | 14 | 58 | — | 37.5 | C-C |
| 7 | F | 12 | 49 | — | 37.5 | C-C |
| 8 | F | 9 | 61 | HT | 25 | C-C |
| 9 | F | 11 | 24 | — | 32 | C-C |
| 10 | F | 6 | 35 | HT | 37.5 | C-C |
| 11 | F | 1 | 52 | Al | 25 | C-C |
| 12 | F | 1 | 26 | — | n/a | C-C |
| 13 | M | 2 | 26 | — | 37.5 | T-C |
| 14 | F | 0 | 21 | — | 50 | T-C |
| 15 | F | 1 | 30 | T1D, HT | 25 | T-C |
| 16 | M | 1 | 60 | — | n/a | T-C |
| 17 | F | 0 | 40 | HT | 37.5 | T-C |
| 18 | F | 60 | 80 | — | 31.25 | T-T |
| 19 | F | 0 | 44 | T1D, HT | n/a | T-T |
Al, alopecia; Gr, graves; HT, Hashimoto's thyroiditis; n/a, not available; PTPN22, phosphatase nonreceptor type 22; T1D, type 1 diabetes; V, vitiligo.